BioWorld

March 19, 2004

View Archived Issues

Depomed Preparing NDA With Positive Ciprofloxacin GR Data

Depomed Inc.'s new formulation of ciprofloxacin HCl achieved top-notch results in a Phase III trial of urinary tract infections. (BioWorld Today) Read More

FDA Seeking Industry Input On Improving Medical Applications

Read More

Antigenics Pockets $14.25M For Sale Of Feline Leukemia Vaccine

Read More

Focusing On MPSS, Lynx Drops Staff By 15 Percent

Read More

Other News To Note

Read More

U.S. Patent Disclosures

Read More